Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹20,056Cr
Rev Gr TTM
Revenue Growth TTM
12.36%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

ATUL
VS
| Quarter | Jun 2023 | Sep 2023 | Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -20.0 | -19.7 | -10.3 | 1.4 | 11.8 | 16.7 | 24.5 | 19.8 | 11.8 | 11.4 | 11.1 | 15.1 |
| 1,000 | 1,039 | 986 | 1,065 | 1,099 | 1,150 | 1,193 | 1,229 | 1,243 | 1,284 | 1,327 | 1,389 |
Operating Profit Operating ProfitCr |
| 15.4 | 13.0 | 13.3 | 12.2 | 16.9 | 17.4 | 15.8 | 15.4 | 15.9 | 17.2 | 15.7 | 16.8 |
Other Income Other IncomeCr | 10 | 24 | 17 | 16 | 16 | 35 | 19 | 50 | 28 | 50 | 40 | 92 |
Interest Expense Interest ExpenseCr | 2 | 2 | 2 | 5 | 5 | 9 | 4 | 5 | 5 | 5 | 4 | 4 |
Depreciation DepreciationCr | 52 | 54 | 61 | 76 | 77 | 78 | 81 | 82 | 82 | 81 | 80 | 79 |
| 138 | 124 | 105 | 83 | 158 | 191 | 158 | 186 | 177 | 231 | 203 | 289 |
| 36 | 32 | 33 | 24 | 46 | 51 | 41 | 56 | 45 | 49 | 40 | 78 |
|
Growth YoY PAT Growth YoY% | -37.6 | -38.4 | -30.0 | -36.2 | 9.8 | 52.9 | 62.5 | 121.3 | 18.1 | 30.7 | 39.7 | 62.2 |
| 8.6 | 7.6 | 6.3 | 4.8 | 8.5 | 10.0 | 8.3 | 9.0 | 9.0 | 11.8 | 10.4 | 12.6 |
| 35.0 | 30.6 | 24.0 | 19.8 | 38.0 | 46.5 | 36.9 | 43.0 | 43.4 | 60.9 | 54.6 | 71.4 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|
|
| | -2.3 | 9.2 | 16.3 | 22.5 | 1.4 | -8.8 | 36.2 | 6.8 | -12.9 | 18.1 | 12.4 |
| 2,255 | 2,135 | 2,324 | 2,791 | 3,271 | 3,191 | 2,814 | 4,169 | 4,653 | 4,089 | 4,670 | 5,243 |
Operating Profit Operating ProfitCr |
| 15.1 | 17.7 | 18.0 | 15.3 | 19.0 | 22.0 | 24.6 | 17.9 | 14.3 | 13.5 | 16.4 | 16.4 |
Other Income Other IncomeCr | 10 | 39 | 57 | 30 | 40 | 83 | 110 | 84 | 119 | 68 | 120 | 209 |
Interest Expense Interest ExpenseCr | 26 | 28 | 25 | 13 | 7 | 9 | 9 | 9 | 8 | 11 | 24 | 17 |
Depreciation DepreciationCr | 60 | 66 | 95 | 110 | 119 | 130 | 136 | 177 | 198 | 243 | 317 | 322 |
| 326 | 404 | 446 | 412 | 680 | 845 | 882 | 810 | 688 | 451 | 692 | 901 |
| 99 | 130 | 123 | 131 | 244 | 175 | 222 | 205 | 181 | 127 | 194 | 211 |
|
| | 21.3 | 17.9 | -13.0 | 55.0 | 53.9 | -1.6 | -8.4 | -16.2 | -36.0 | 53.9 | 38.2 |
| 8.5 | 10.6 | 11.4 | 8.5 | 10.8 | 16.4 | 17.7 | 11.9 | 9.3 | 6.9 | 8.9 | 11.0 |
| 81.1 | 92.5 | 109.0 | 94.8 | 145.7 | 224.7 | 221.2 | 204.2 | 174.2 | 109.5 | 164.4 | 230.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|
Equity Capital Equity CapitalCr | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 29 | 29 | 29 |
| 1,009 | 1,585 | 1,936 | 2,214 | 2,676 | 3,125 | 3,797 | 4,399 | 4,642 | 5,085 | 5,569 | 6,193 |
Current Liabilities Current LiabilitiesCr | 638 | 706 | 588 | 569 | 577 | 732 | 806 | 999 | 840 | 888 | 884 | 1,122 |
Non Current Liabilities Non Current LiabilitiesCr | 140 | 156 | 158 | 181 | 237 | 237 | 274 | 248 | 208 | 424 | 455 | 482 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 1,041 | 1,059 | 1,127 | 1,355 | 1,662 | 2,082 | 2,564 | 2,689 | 2,091 | 2,276 | 2,945 | 4,056 |
Non Current Assets Non Current AssetsCr | 782 | 1,420 | 1,600 | 1,658 | 1,882 | 2,069 | 2,373 | 3,017 | 3,677 | 4,201 | 4,056 | 3,845 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|
Operating Cash Flow Operating Cash FlowCr | 306 | 401 | 392 | 356 | 404 | 881 | 718 | 231 | 707 | 667 | 603 | 1,023 |
Investing Cash Flow Investing Cash FlowCr | -167 | -375 | -173 | -130 | -407 | -783 | -646 | -168 | -469 | -683 | -495 | -895 |
Financing Cash Flow Financing Cash FlowCr | -124 | -39 | -212 | -207 | -1 | -111 | -52 | -57 | -257 | 38 | -118 | -98 |
|
Free Cash Flow Free Cash FlowCr | 129 | 31 | 180 | 213 | 195 | 508 | 396 | -359 | -167 | 164 | 334 | |
| 135.4 | 146.2 | 121.2 | 126.5 | 92.6 | 131.4 | 108.8 | 38.3 | 139.5 | 205.9 | 120.9 | 148.4 |
CFO To EBITDA CFO To EBITDA% | 76.3 | 87.3 | 76.9 | 70.4 | 52.6 | 97.7 | 78.3 | 25.4 | 91.2 | 104.8 | 66.1 | 99.2 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 3,345 | 4,570 | 7,059 | 7,777 | 10,597 | 11,789 | 20,935 | 30,440 | 20,544 | 16,894 | 18,058 | 18,763 |
Price To Earnings Price To Earnings | 14.2 | 16.7 | 21.9 | 28.1 | 24.5 | 17.7 | 31.9 | 50.4 | 40.0 | 52.3 | 37.3 | 27.7 |
Price To Sales Price To Sales | 1.3 | 1.8 | 2.5 | 2.2 | 2.6 | 2.9 | 5.6 | 6.0 | 3.8 | 3.6 | 3.2 | 3.0 |
Price To Book Price To Book | 3.2 | 2.8 | 3.6 | 3.5 | 3.9 | 3.7 | 5.5 | 6.9 | 4.4 | 3.3 | 3.2 | 3.0 |
| 8.8 | 10.5 | 14.1 | 15.3 | 13.8 | 13.1 | 22.6 | 33.5 | 26.5 | 26.8 | 19.9 | 18.3 |
Profitability Ratios Profitability Ratios |
| 45.6 | 48.9 | 49.4 | 45.3 | 47.8 | 51.9 | 54.6 | 49.0 | 47.2 | 46.9 | 50.8 | 37.0 |
| 15.1 | 17.7 | 18.0 | 15.3 | 19.0 | 22.0 | 24.6 | 17.9 | 14.3 | 13.5 | 16.4 | 16.4 |
| 8.5 | 10.6 | 11.4 | 8.5 | 10.8 | 16.4 | 17.7 | 11.9 | 9.3 | 6.9 | 8.9 | 11.0 |
| 27.6 | 22.8 | 22.3 | 18.8 | 24.9 | 26.3 | 22.5 | 17.9 | 14.7 | 8.6 | 12.3 | 14.3 |
| 21.8 | 17.0 | 16.4 | 12.5 | 16.1 | 21.3 | 17.3 | 13.7 | 10.8 | 6.3 | 8.9 | 11.1 |
| 12.4 | 11.1 | 11.9 | 9.3 | 12.3 | 16.2 | 13.4 | 10.6 | 8.8 | 5.0 | 7.1 | 8.7 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Atul Ltd, founded on **September 5, 1947**, by **Mr. Kasturbhai Lalbhai**, is one of India’s largest **integrated chemical companies**, with a legacy of over 75 years. Headquartered in Gujarat, the company operates across a diverse portfolio of chemical products and formulations, serving approximately **4,000 customers across 30 industries in around 82–83 countries**. With annual revenue approaching ₹5,000 crore, Atul has evolved from a traditional B2B chemical manufacturer to a diversified enterprise with growing **B2C retail operations** in crop protection and polymers.
The company maintains a strong global presence through subsidiaries in **Brazil, China, the UAE, the UK, and the USA**, and manages **eight manufacturing sites** across India (Ankleshwar, Atul, Panoli, Tarapur, Ambernath, Valsad, Jodhpur) and the UK (Somerset).
---
### **Business Segments & Portfolio**
Atul operates across a broad and integrated value chain, organized into two primary revenue categories:
1. **Life Science Chemicals** – APIs, intermediates, agrochemicals, bioscience products.
2. **Performance and Other Chemicals** – Aromatics, bulk chemicals, dyes, pigments, polymers, resins, and retail chemicals.
#### **Key Sub-Segments (as of May 2025):**
| Sub-Segment | Key Products | Industries Served | Market Position |
|-------------|--------------|-------------------|-----------------|
| **Pharmaceuticals (APIs & Intermediates)** | Dapsone, anti-diabetic, anti-inflammatory APIs | Pharma | 50% market share in India/Europe for Dapsone; FDA-approved Ambernath site |
| **Crop Protection – Bulk & Retail** | Herbicides (2,4-D), Insecticides (Indoxacarb), Fungicides, Biostimulants | Agriculture | 13% share in 2,4-D, 15% in Indoxacarb; 58 brands, 71 formulations |
| **Polymers – Performance Materials** | Epoxy resins, sulfones, curing agents, reactive diluents | Aerospace, composites, wind energy, electronics | Leading share in India for epoxy resins; significant global sulfone presence |
| **Polymers – Retail** | Adhesives (epoxy, PU, synthetic rubber) | Footwear, construction, automotive | Brands: Lapox (7%), Polygrip (5%) – competing with Fevicol, Araldite |
| **Colors** | Vat dyes, Sulphur black, High-performance pigments | Textiles, paints, paper | Strong India presence in Vat/Sulphur dyes; limited global pigment share |
| **Bulk Chemicals & Intermediates** | Resorcinol, 1,3-CHD, resorcinol resins | Tyres, cosmetics, chemicals | Global leadership in 1,3-CHD; strong domestic resorcinol share |
---
### **Retail Expansion & Brand Portfolio**
Atul is actively building two **B2C retail businesses**, both showing strong momentum:
- **Crop Protection - Retail**: ₹256 crore sales in FY24–25 (+25% YoY), driven by 39% volume growth. Key brands: **Rymix, Amsac, Lepto, Sindica (launched March 2024)**.
- **Polymers - Retail**: Sales from adhesives segment growing steadily. Portfolio includes **3 primary brands, 76 sub-brands, ~600 customers**.
Sindica, a **patented post-emergence herbicide** for sugarcane, combines 2,4-D Sodium, Metribuzin, and Chlorimuron ethyl—targeting broadleaf weeds, grasses, and sedges with no adverse soil impact. Commercial launch in India was in **March 2024**, with international market studies underway.
---
### **Subsidiaries & Joint Ventures (as of Jul 2025)**
| Entity | Ownership | Key Developments |
|--------|-----------|------------------|
| **Atul Products (100%)** | Fully owned | Sales up from ₹65Cr to ₹353Cr; expects **PBT positivity by 2025–26** |
| **Anaven LLP (50-50 with Nouryon)** | JV | Sales grew from ₹73Cr to ₹86Cr; **EBITDA positive**; ₹125Cr sales potential |
| **Atul Rajasthan Date Palms (74-26 Govt. of Rajasthan)** | JV | Technology refinement ongoing; output expected to improve gradually |
| **Atul Bioscience Ltd (100%)** | Fully owned | Sales: ₹132Cr → ₹137Cr; **USFDA approval at Ambernath**; zero 483 observations; launched 2 new products in U.S./EU |
| **DPD (98%)** | Majority-owned | Sales: £4.7M → £5M; potential for **50% growth**; capacity doubled in 2020 |
| **Rudolf Atul Chemicals Ltd (RACL) (50-50)** | JV with Rudolf Group | Record sales of ₹167Cr, PBT ₹36Cr; aims to grow market share in textile chemicals |
---
### **Financial Performance (2024–25)**
- **Total Revenue**: ₹4,719.12 crore
- External: ₹4,533.06 crore
- Inter-segment: ₹240.47 crore (evidencing strong internal integration)
- **Exports**: ₹2,187.87 crore (**43% of turnover**)
- **Life Science Chemicals**: ₹1,519.96 crore (up from ₹1,257.29Cr)
- **Performance & Other Chemicals**: ₹3,730.09 crore (up from ₹3,272.86Cr)
---
### **Innovation & R&D**
- **R&D Investment**: ₹41 crore (Jul 2025), supported by **10 labs and 242 researchers**.
- Focus on **APIs, agrochemicals, polymers, dyes**, and sustainable chemistry.
- **Atul Bioscience**: Scaling up two products, commercializing two new APIs and intermediates.
- Multiple **new product launches** in crop protection and polymers (10 in 2024–25).
---
### **Sustainability & Infrastructure**
- **Zero Liquid Discharge (ZLD)**: Achieved at **five manufacturing sites**.
- **Captive Power**: 73 MW
- **Effluent Treatment**: 32 MLD capacity
- **Backward Integration**: Strong cost control via in-house production of key intermediates.
- **Debt-free balance sheet** – funded via internal accruals and shareholder capital.
---
### **Manufacturing & Operations**
- **8 consolidated manufacturing sites** across India and the UK.
- Portfolio of **~900 products, 400 formulations, 140 brands**.
- **1,300+ employees** (approx. 3,000 across group), ~3,643 suppliers, ~2,000 distributors, ~38,000 retailers.
- **Digital transformation** underway: enhancing website, social media, and channel engagement.
---
### **Growth Strategy (as of 2025)**
1. **Organic Expansion**:
- Launch new products in crop protection, polymers, and life sciences.
- Strengthen distribution in India and expand geographically.
2. **Retail Scale-Up**:
- Accelerate **Crop Protection** and **Polymers Retail** businesses.
- Target **₹250–350 crore+ sales** in each retail segment.
3. **Capacity Utilization**:
- Maximize output at new plants (e.g., Anaven MCA facility, new Polymers plant).
- Debottlenecking and capacity expansion in para-Cresol, resorcinol, dyes.
4. **Market Penetration**:
- Increase presence in **epoxy, wind energy, technical textiles, adhesives**.
- Expand RACL’s footprint in **denim, printing, synthetic textiles**.
5. **Inorganic Opportunities**:
- Evaluate strategic acquisitions in Fragrance, Personal Care, and Crop Protection.
6. **Sustainability**:
- Promote green chemistry, energy efficiency, and circular processes.